{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1383388845512434433.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"Jan Adolfsson"}],"foaf:familyName":[{"@value":"Adolfsson"}],"foaf:givenName":[{"@value":"Jan"}]}],"career":[{"institution":{"notation":[{"@value":"Sean O'Farrell, Hans Garmo, Lars Holmberg, and Mieke Van Hemelrijck, King's College London, School of Medicine; Sean O'Farrell, Guy's and St Thomas' National Health Service Foundation Trust and King's College London's Comprehensive Biomedical Research Centre, London, United Kingdom; Hans Garmo and Lars Holmberg, Regional Cancer Centre, Uppsala Örebro; Lars Holmberg, Uppsala University, Uppsala; Jan Adolfsson and Mieke Van Hemelrijck, Karolinska Institutet, Stockholm; and Pär Stattin, Umeå University,..."}]}}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1363388845512434432","@type":"Article","productIdentifier":[{"@type":"DOI","@value":"10.1200/jco.2014.59.1792"},{"@type":"URI","@value":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2014.59.1792"}],"notation":[{"@value":"Risk and Timing of Cardiovascular Disease After Androgen-Deprivation Therapy in Men With Prostate Cancer"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1200/jco.2014.59.1792_WksznRgDXXQaawK9e7vr5kbezqn"}]}